What data from clinical trials do the FDA consider when approving new drugs for solid tumors?

Edward Li, PharmD, MPH, BCOP

Edward Li, PharmD, MPH, BCOP, on solid tumors: new drug approvals.


Copyright © 2016 Harborside Press, LLC All rights reserved.                Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact
Copyright Notice/Disclaimer
Bot trap - Don't go here